Clinical trial
Paclitaxel and ABI-007 in Treating Patients With Locally Advanced or Metastatic…
NCT00095914 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00095914 |
|---|---|
| Title | Paclitaxel and ABI-007 in Treating Patients With Locally Advanced or Metastatic Solid Tumors |
| Official title | Randomized, Crossover, Pharmacokinetic Study Of Paclitaxel (Taxol) And ABI-007 (A Cremophor EL-Free, Protein Stabilized, Nanoparticle Paclitaxel) In Patients With Advanced Solid Tumors |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | paclitaxel, paclitaxel albumin-stabilized nanoparticle formulation |
| Start date | Sep 1, 2004 |
| Primary completion | May 1, 2007 |
| Completion | Mar 1, 2009 |
| First posted | Nov 9, 2004 |
| Last update posted | Mar 15, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: